Resources

GABAA receptor autoimmunity February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/

Learn more
Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624087/

Learn more
The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221172/

Learn more
Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle? February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746826/

Learn more
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980521/

Learn more
Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1 February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119747/

Learn more
Autoimmune epilepsy: findings on MRI and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435058/

Learn more
LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156957/

Learn more
The short-term efficacy of combined treatments targeting B cell and plasma cell in severe and refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436585/

Learn more
Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086890/

Learn more